Mualliflar

  • Sadokat Yuldashevna Avezova

##semicolon##

ischemic stroke, urinary callidinogenase, rivaroxaban, hemostasis.

##submission.citations##

WHO. The top 10 causes of death. 2018.

Go A.S., Mozaffarian D., Roger V.L. et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 2020; 129: e28–92.

Wang W., Jiang B., Sun H. et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation 2017; 135:759–71.

Amarenco P., Bogousslavsky J., Caplan L.R. et al. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis 2019; 36:1–5.

Grysiewicz R.A., Thomas K., Pandey D.K. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008; 26:871–95. vii.

El-Koussy M., Schroth G., Brekenfeld C. et al. Imaging of acute ischemic stroke. Eur Neurol 2014; 72:309–16.

Yew K.S., Cheng E.M. Diagnosis of acute stroke. Am Fam Physician 2015; 91:528–36.

Montecucco F., Mach F. Atherosclerosis is an inflammatory disease. Semin Immunopathol 2019; 31:1–3.

Tuttolomondo A., Di Sciacca R., Di Raimondo D. et al. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. Int J Cardiol 2018; 151:318–22.

Di Raimondo D., Tuttolomondo A., Butta C. et al. Effects of ACEinhibitors and angiotensin receptor blockers on inflammation. Curr Pharm Des 2012; 18:4385–413.

Di Raimondo D., Tuttolomondo A., Butta C. et al. Metabolic and antiinflammatory effects of a home-based programme of aerobic physical exercise. Int J Clin Pract 2020; 67:1247–53.

Reshi R., Streib C., Ezzeddine M. et al. Hyperglycemia in acute ischemic

stroke: Is it time to reevaluate our understanding? Med Hypotheses 2017; 107:78–80.

Gonzalez-Moreno E.I., Camara-Lemarroy C.R. Gonzalez-Gonzalez JG,et al. Glycemic variability and acute ischemic stroke: the missing link? Transl Stroke Res 2014; 5:638–46.

Licata G., Tuttolomondo A., Corrao S. et al. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol 2019 19:639–46.

Kruyt N.D., Biessels G.J., Devries J.H. et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010; 6:145–55.